KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
The health emergency has led international health agencies, including the World Health Organization, to assist local medical teams with logistics, laboratory testing, and vaccine distribution. Authorities are administering the Ervebo vaccine under a compassionate-use framework while researchers gather observational data on its effectiveness against the circulating viral strain in the region. DR Congo initiates Ebola vaccination efforts as health workers reinforce ring-vaccination strategies around infection clusters to contain transmission chains.
Health Ministry Focuses on Ervebo Vaccine for Kisangani Healthcare Professionals
Operational challenges persist due to regional infrastructure issues, ongoing security concerns, and high population movement across borders. Cold-chain logistics have been established in Kisangani to ensure the vaccine’s storage at ultra-low temperatures before distribution to remote health zones. The DR Congo government launches Ebola vaccination efforts, with civil defense and community health workers conducting outreach to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are partnering with local teams to monitor adverse events and assess immune responses among vaccinated populations. Officials stressed that early detection, combined with isolation measures and supportive treatment, remains vital for improving patient outcomes. Additional vaccine supplies are scheduled for delivery as regional distribution expands to secondary health districts.
Authorities Reinforce Strict Infection Control Practices in Ebola Treatment Centers
Contact-tracing operations are being extended by national response teams across urban and rural areas of the eastern region. Local health facilities are supplied with protective gear, diagnostic reagents, and treatment supplies to bolster readiness. Government agencies have confirmed that comprehensive public health measures will stay in effect until transmission rates show consistent decline across all affected provinces.
The government has urged communities to cooperate fully with mobile vaccination teams and follow established health protocols. Increasing immunization coverage among high-risk groups is expected to stabilize infection levels in the coming weeks, with surveillance maintained at transportation hubs and border crossings to prevent further spread.